Alloy M4 Products Are Backed By An Independent 12-week Clinical Study
7 minute read

Summary
Hormonal shifts during perimenopause and menopause can significantly affect skin structure, leading to dryness, thinning, reduced elasticity, and increased wrinkles. Estrogen plays a key role in collagen production, hydration, and skin barrier function, which explains why declining levels often accelerate visible aging. Clinical research on topical estrogen-based skincare has explored whether targeted treatments can improve elasticity, hydration, and overall skin quality. Interpreting study design, participant populations, and outcome measurements can help women understand what clinical results may mean for their own skincare choices during midlife.
While you may have had a skincare routine that worked perfectly for years, as your hormones fluctuate, your skin’s needs can change, too.
It’s possible that the cleansers, serums, and moisturizers you once swore by are no longer giving you the same plump, hydrated glow. Instead, you may be dealing with dryness, crepey texture, or skin that suddenly feels thinner or more sensitive than before.
Know this: These changes are not a sign that you’re doing something wrong! As estrogen levels begin to fluctuate and decline during perimenopause, your skin needs change along with it.
More women are looking for solutions specifically designed for hormonal skin aging, and menopause-focused skincare has become a rapidly growing category. That includes prescription topical estrogen products like estriol-based face creams, which are now being studied in clinical trials designed specifically for midlife skin.
Why Skin Changes During Perimenopause and Menopause
Estrogen plays many behind-the-scenes roles in skin health. It’s one of the hormones that helps skin maintain its structure and resilience by supporting collagen production, hydration, elasticity, and overall skin thickness.
So when estrogen levels begin fluctuating up and down during perimenopause before bottoming out in menopause, the effects can become visible fairly quickly. Your skin may feel thinner, drier, duller, or less firm than it used to, despite staying consistent with your skincare routine. Some women also notice increased sensitivity or feel like their skin takes longer to recover from irritation.
Fine lines and crepiness can become more noticeable as collagen production slows, especially during the first couple of years after menopause, when collagen loss tends to accelerate most rapidly.
And of course, hormonal skin changes aren’t happening in a vacuum. Your skin is also navigating everyday environmental stressors like sun exposure, pollution, and cigarette smoke (if that applies to you), all of which can further amplify changes to your skin texture and overall skin health.
What the 12-Week M4 Clinical Study Was Designed to Test
Alloy’s M4 Face Cream Rx was evaluated in an independent clinical study, where researchers evaluated how an estriol-based prescription cream affected menopause-related skin concerns over 12 weeks. The study focused on changes in hydration, elasticity, texture, and overall skin quality.
The 12-week timeframe matters in this context because it takes time before you start to notice changes in your skin after a change in your routine. Clinical studies like this also rely on more than just participant opinions. Researchers often use a combination of expert evaluations, imaging technology, hydration measurements, and elasticity assessments to track changes throughout the study period.
“Our 12 week trials at Alloy Health show robust evidence of clinical efficacy and our patients are noticing visible results especially with continued use” ~ Dr Sheila Boyle
Placebo comparisons help determine whether improvements are likely related to the treatment itself.
Who Participated in the Study—and Why That Matters
Any woman in perimenopause and menopause knows that their skin behaves differently now than it did before. That’s exactly why younger, premenopausal women aren’t the appropriate sample study, because their naturally higher estrogen levels may not tell you much about how it performs on postmenopausal skin experiencing collagen loss, dryness, and thinning.
The M4 study focused specifically on 40 women, between the ages of 40 and 70 years old, experiencing hormonal skin aging linked to perimenopause and menopause, making the results more relevant for women navigating those same concerns themselves. The women among this diverse sample were either taking hormone replacement therapy, oral contraceptives, or nothing at all, and were all considered generally healthy at the start of the study.
What Results Were Reported After 12 Weeks
According to company-reported findings from the 12-week study, participants experienced improvements in hydration, elasticity, texture, and overall skin appearance.
Some of the results were especially notable. Elasticity reportedly improved by up to 88%, while hydration improved by roughly 70% over the 12-week study.
“Restoration of skin elasticity and hydration provide a more youthful skin quality with improved firmness, so our skin appears more supple and smoother over time” ~Dr Sheila Boyle
Researchers also noted that changes became more noticeable between weeks eight and 12. Again, it takes time to see results. Slow and steady wins the race!
Remember, clinical studies like this one measure trends across groups of participants, which means the results shouldn't be interpreted as hyper-individualized advice. Some women may notice more noticeable changes than others, depending on factors like skin type, consistency, environmental exposure, and hormonal changes happening in their bodies.
TL;DR: study results help show what’s possible, not necessarily what’s guaranteed.
How Topical Estrogen Can Affect Skin
Estriol-based skincare works differently from a traditional drugstore moisturizer. While hydrating products mainly help replenish moisture at the surface, topical estrogen-based skincare is designed to address some of the underlying biological changes happening in estrogen-deficient skin.
Again, estrogen supports the production of collagen, which in part affects skin thickness, elasticity, hydration retention, and barrier function. Topical estriol works locally within the skin itself, versus taking systemic HRT, which can help address other menopausal symptoms like hot flashes and mood swings.
Research on topical estrogen has long shown improvements in hydration, elasticity, wrinkle depth, and collagen support. Sure, no skincare product completely stops skin aging, but supporting your skin’s structural integrity during this life stage may help you feel more comfortable and confident in your skin.
How to Interpret Clinical Evidence in Skincare
This PSA goes for any clinical claims for any product: context matters. A statistically significant result means researchers observed measurable differences that likely weren’t due to chance. What it doesn’t mean? Every participant looked dramatically different after a few weeks. Study length matters. As does sample size, placebo comparisons, and the tools researchers use to measure outcomes. Some studies rely heavily on subjective participant feedback, while others use imaging technology, hydration sensors, or high-tech grading systems to assess changes from a more objective lens.
Independent studies also tend to build more confidence in product claims because they introduce more separation between the company and the reported results.
Ultimately, clinical evidence should be viewed as one piece of the larger picture, not the only factor guiding your skincare decisions. Your personal experience with a product matters most!
How M4 Products Fit Into a Menopause Skincare Routine
When building out your menopause skincare routine, you’ll want to focus on a few goals: supporting hydration, maintaining your skin barrier, and helping preserve collagen and elasticity as estrogen levels decline.
That’s why ingredients like hyaluronic acid, peptides, and estriol often appear together in menopause-focused formulations. Each ingredient supports a slightly different area of your overall skin health.
For example, hydrators help replenish moisture, whereas peptides support collagen signaling and repair pathways. Estriol is unique in the sense that it helps address some of the hormonal shifts affecting skin structure and firmness.
Of course, we can’t forget to call out the eye area. This is often one of the first places women start to clock signs of skin aging. That’s because the skin there is naturally thinner and more delicate. Targeted eye creams can also be an instrumental part of your personal menopause skincare routines.
Products like M4 can often be layered into your existing skincare routine, depending on your skin type, goals, and overall care plan. Always check with your care team first, before introducing a new product or supplement, to make sure there aren’t any contraindications with anything else you’re currently taking.
Frequently Asked Questions
What were the specific findings of the M4 Face Cream clinical study regarding skin elasticity and hydration?
The independent clinical study for M4 Face Cream Rx reported significant measurable improvements in skin quality over a 12-week period. According to company-reported findings, participants saw elasticity improve by up to 88%, while skin hydration levels increased by approximately 70%. These results indicate that the estriol-based formulation effectively addresses the structural depletion of collagen and moisture that occurs when estrogen levels decline during midlife. Researchers noted that these visible changes in firmness and suppleness became most noticeable between the eight and 12-week marks of consistent use.
Who was included in the M4 clinical study and why was this specific group chosen?
The study focused on a diverse group of 40 women between the ages of 40 and 70 who were experiencing hormonal skin aging related to perimenopause and menopause. This specific demographic was chosen because younger, premenopausal women have naturally higher estrogen levels, which would not accurately reflect how the product performs on estrogen-deficient skin. The participants included women who were using hormone replacement therapy, those on oral contraceptives, and those taking no hormonal treatments at all, ensuring the results were relevant to a wide range of women navigating the menopause transition.
How does topical estriol differ from traditional moisturizers in addressing skin aging?
Unlike traditional drugstore moisturizers that primarily focus on replenishing moisture at the surface level, topical estriol is designed to address the underlying biological changes of estrogen-deficient skin. Estrogen is a key driver of collagen production and skin thickness; as it declines, the skin’s structural integrity weakens. Estriol-based skincare works locally within the skin to support collagen density and barrier function from within. While it does not completely stop the aging process, it targets the hormonal root causes of thinning and crepiness, whereas standard hydrators only provide temporary surface-level relief.
Related Content
Citations
Elaine Emmerson, Matthew J. Hardman. The role of estrogen deficiency in skin ageing and wound healing. Biogerontology 2011;13(1):3-20. doi:10.1007/s10522-011-9322-y.
View sourceArcher DF. Postmenopausal skin and estrogen. Gynecol Endocrinol. 2012;28 Suppl 2:2-6. PMID:22849791.
View sourceYu Yu Shu, Howard I Maibach. Estrogen and skin: therapeutic options. Am J Clin Dermatol 2011;12(5):297-311. PMID:21714580.
View sourceDavid A Sullivan, Benjamin D Sullivan, James E Evans, Frank Schirra, Hiroko Yamagami, Meng Liu, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211-22. PMID:12114274.
View sourceM G Shah, H I Maibach. Estrogen and skin. An overview. Am J Clin Dermatol 2001;2(3):143-50. PMID:11705091.
View sourceJ L Bolognia, I M Braverman, M E Rousseau, P M Sarrel. Skin changes in menopause. Maturitas 1989;11(4):295-304. PMID:2693917.
View source
Subscribe
Go ahead, you deserve to
feel fantastic
By subscribing you agree to our Terms of Service & Privacy Policy.

